Trial Profile
A phase 1 study of OralVac in house dust mites.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Dec 2017
Price :
$35
*
At a glance
- Drugs Allergy immunotherapy (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions
- 20 Dec 2017 New trial record